Contact

Stephanie Geyer
Stephanie Geyer
Phone: +49 391 6110 461
Fax: +49 391 6110 551
Room: S1.12

Upcoming events

International Max Planck Research School (IMPRS)

Header image 1502463323

International Max Planck Research School

International Max Planck Research School Magdeburg for Advanced Methods in Process and Systems Engineering - IMPRS ProEng

The International Max Planck Research School Magdeburg is a joint initiative of the Max Planck Institute for Dynamics of Complex Technical Systems and the Otto von Guericke University in Magdeburg. Its main goal is to provide excellent training and PhD projects concerning analysis, design and optimization in chemical and biochemical process engineering.

The focus is on the development and the application of mathematical modeling approaches and system theoretical methods used to identify system structures, investigate process behavior and design technical processes for specific tasks.

Latest news

Teaser 1530263754

IMPRS graduate Dr. Jessica Bosch awarded the Otto Hahn Medal

June 29, 2018
Prestigious prize for junior scientists of the Max Planck Society was given for her work on the development of fast and robust solvers for phase field problems from many application areas [more]
Teaser 1525698801

IMPRS opens new social media channel

Now you can also follow us and get in touch with our scientists at the Linkedin professional platform [more]
Original 1523266646

Dr. Matthias Stein was elected Fellow of the Royal Society of Chemistry

April 09, 2018
Dr. Matthias Stein, head of the research group Molecular Simulations and Design at the Max Planck Institute for Dynamics of Complex Technical Systems Magdeburg, has been elected as a Fellow of the Royal Society of Chemistry (FRSC). [more]
Original 1524670478

IMPRS scientists meet for workshop in Goslar

April 08, 2018
Students presented their latest findings during the school's annual scientific retreat [more]
Original 1519220276

Fighting Malaria with Green Chemical Synthesis

February 26, 2018
A new production process could make the active ingredient artemisinin available to millions of malaria patients all over the world [more]

 
Go to Editor View
loading content